BEAM THERAPEUTICS INC shareholders Q3 2022

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

BEAM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Kessler Investment Group, LLC 1,740$83,0000.07%
SG3 Management, LLC 20,000$952,4000.06%
TWINBEECH CAPITAL LP 50,216$2,392,0000.06%
Rafferty Asset Management, LLC 123,925$5,904,0000.06%
GSA CAPITAL PARTNERS LLP 9,217$439,0000.06%
Woodline Partners LP 83,134$3,961,0000.06%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 214,220$10,205,0000.06%
XTX Topco Ltd 4,524$216,0000.05%
Virtu Financial LLC 10,267$489,0000.04%
TUDOR INVESTMENT CORP ET AL 40,839$1,946,0000.04%
GUGGENHEIM CAPITAL LLC 87,530$4,169,0000.04%
E Fund Management Co., Ltd. 8,283$395,0000.04%
Trexquant Investment LP 22,234$1,059,0000.04%
Engineers Gate Manager LP 12,025$573,0000.04%
Y-Intercept (Hong Kong) Ltd 6,911$329,2400.03%
TWO SIGMA INVESTMENTS, LP 198,996$9,480,0000.03%
Mirae Asset Global Investments Co., Ltd. 246,364$11,737,0000.03%
Avidian Wealth Solutions, LLC 9,400$448,0000.03%
Hemenway Trust Co LLC 5,680$271,0000.03%
Tekla Capital Management LLC 15,817$754,0000.03%
External links

This page lists BEAM THERAPEUTICS INC's shareholders in Q3 2022. To view BEAM THERAPEUTICS INC's shareholder history, click here.